Gene expression profiles as prognostic factors in patients with multiple myeloma treated with conventional versus novel agents in correlation with outcome

被引：0
|
作者：
Broyl, Annemiek [1 ]
Hose, Dirk [3 ]
De Knegt, Yvonne [1 ]
Lokhorst, Henk [2 ]
Goldschmidt, Hartmut
Van Duin, Mark [1 ]
Sonneveld, Pieter [1 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
[3] Univ Heidelberg, Heidelberg, Germany
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.3173.3173
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3173
引用
收藏
页码：932A / 932A
页数：1
相关论文
共 50 条
  • [1] Prognostic significance of apoptotic index in multiple myeloma patients treated by conventional therapy and novel agents, thalidomide and bortezomib
    Minarik, Jiri
    Scudla, Vlastimil
    Ordeltova, Marta
    Bacovsky, Jaroslav
    Pika, Tomas
    Langova, Katerina
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 83 (06) : 528 - 534
  • [2] Gene expression profiles as prognostic factors for high-dose therapy and bortezomib in patients with multiple myeloma
    Broyl, A.
    Hose, D.
    de Knegt, Y.
    Lokhorst, H.
    Goldschmidt, H.
    Sonneveld, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 257 - 257
  • [3] Gene expression profiles as prognostic factors for high-dose therapy and bortezomib in patients with multiple myeloma
    Broyl, A.
    Hose, D.
    De Knegt, Y.
    Lokhorst, H.
    Goldschmidt, H.
    Sonneveld, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 65 - 65
  • [4] Prognostic:: factors for multiple myeloma in the era of novel agents
    Blade, J.
    Rosinol, L.
    Cibeira, M. T.
    ANNALS OF ONCOLOGY, 2008, 19 : 117 - 120
  • [5] Multiple myeloma in elderly patients: prognostic factors and outcome
    Anagnostopoulos, A
    Gika, D
    Symeonidis, A
    Zervas, K
    Pouli, A
    Repoussis, P
    Grigoraki, V
    Anagnostopoulos, N
    Economopoulos, T
    Maniatis, A
    Dimopoulos, MA
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (05) : 370 - 375
  • [6] Gene expression profiling in patients with plasma cell myeloma treated with novel agents
    Medinger, M.
    Halter, J.
    Heim, D.
    Buser, A.
    Gerull, S.
    Stern, M.
    Passweg, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 172 - 172
  • [7] Gene expression signatures of conventional prognostic factors in multiple
    Kumar, S
    Rajkumar, SV
    Haug, JL
    Shammas, M
    Li, C
    Lacy, MQ
    Dispenzieri, A
    Gertz, MA
    Witzig, TE
    Anderson, KC
    Munshi, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 586S - 586S
  • [8] Gene expression profiles and conventional prognostic factors in breast cancer
    Pedrazaa, V.
    Gomez Capillab, J. A.
    Tornec, P.
    Rivera Pomard, J. M.
    Farezb, E.
    Gilb, A.
    Suarezb, A.
    Gomez-Llorenteb, C.
    Oleaa, N.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81
  • [9] EXPRESSION OF MET MRNA AS PROGNOSTIC MARKER IN MULTIPLE MYELOMA PATIENTS TREATED WITH NOVEL DRUGS
    Rocci, A.
    Gambella, M.
    Trusolino, L.
    Gay, F.
    Omede, P.
    Magarotto, V.
    Bertotti, A.
    Montefusco, V.
    Crippa, C.
    Patriarca, F.
    Gilestro, M.
    Liberati, A. M.
    Gaidano, G.
    Di Raimondo, F.
    Falcone, A.
    Rossi, G.
    Drandi, D.
    Corradini, P.
    Ladetto, M.
    Comoglio, P.
    Boccadoro, M.
    Palumbo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 134 - 134
  • [10] Gene-expression Profiling in Patients with Plasma Cell Myeloma Treated with Novel Agents
    Medinger, Michael
    Halter, Joerg
    Heim, Dominik
    Buser, Andreas
    Gerull, Sabine
    Lengerke, Claudia
    Passweg, Jakob
    CANCER GENOMICS & PROTEOMICS, 2016, 13 (04) : 275 - 279
12345